Expert Review of Pharmacoeconomics & Outcomes Research, Volume 22, Issue 1 (2022)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Review of Pharmacoeconomics & Outcomes Research, Volume 22, Issue 1 (2022)

See all volumes and issues
Vol 24, 2024 Vol 23, 2023 Volume 22, 2022 Vol 21, 2021 Vol 20, 2020 Vol 19, 2019 Vol 18, 2018 Vol 17, 2017 Vol 16, 2016 Vol 15, 2015 Vol 14, 2014 Vol 13, 2013 Vol 12, 2012 Vol 11, 2011 Vol 10, 2010 Vol 9, 2009 Vol 8, 2008 Vol 7, 2007 Vol 6, 2006 Vol 5, 2005 Vol 4, 2004 Vol 3, 2003 Vol 2, 2002 Vol 1, 2001
Download citations Download PDFs Download issue

Letter to the Editor

Letter to the editor regarding “Budget impact analysis of pneumococcal conjugate vaccines in Colombia”
Juan M. Reyes, Jorge LaRotta, Natalia Castano, Mark A. Fletcher, Matthew Wasserman, Johnna Perdrizet & Rodrigo Sini de Almeida
Pages: 1-3
Published online: 04 Oct 2021
First Page PreviewforLetter to the editor regarding “Budget impact analysis of pneumococcal conjugate vaccines in Colombia” | Full Text | References | PDF (134 KB) | EPUB
  • 846 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access
Budget impact analysis of pneumococcal conjugate vaccines in Colombia. Response to letter to the editor
Jorge A. Gomez, Diana Caceres & Edisson Rodriguez
Pages: 5-6
Published online: 06 Oct 2021
CitationforBudget impact analysis of pneumococcal conjugate vaccines in Colombia. Response to letter to the editor | Full Text | References | PDF (141.5 KB) | EPUB
  • 722 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Review

Burden of disease and costs of infections associated with cardiac implantable electronic devices
Daria Sgreccia, Marco Vitolo, Anna Chiara Valenti, Marcella Manicardi & Giuseppe Boriani
Pages: 7-16
Published online: 22 Sep 2021
AbstractforBurden of disease and costs of infections associated with cardiac implantable electronic devices | Full Text | References | PDF (623.5 KB) | EPUB
  • 165 Views
  • 2 CrossRef citations
  • 0Altmetric
Incorporating health inequality impact into economic evaluation in low- and middle-income countries: a systematic review
Fan Yang, Kenneth Roger Katumba & Susan Griffin
Pages: 17-25
Published online: 21 Jul 2021
AbstractforIncorporating health inequality impact into economic evaluation in low- and middle-income countries: a systematic review | Full Text | References | PDF (1.2 MB) | EPUB | Supplemental
  • 3212 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access

Systematic review

A systematic review of cost-effectiveness analyses of continuous versus intermittent renal replacement therapy in acute kidney injury
Ambrish Singh, Salman Hussain, Vijay Kher, Andrew J Palmer, Matthew Jose & Benny Antony
Pages: 27-35
Published online: 02 May 2021
AbstractforA systematic review of cost-effectiveness analyses of continuous versus intermittent renal replacement therapy in acute kidney injury | Full Text | References | PDF (1.6 MB) | EPUB | Supplemental
  • 404 Views
  • 1 CrossRef citations
  • 0Altmetric
Economic evaluation of ivabradine in treatment of patients with heart failure: a systematic review
Asma Rashki Kemmak, Zeinab Dolatshahi, Fateme Mezginejad & Shahin Nargesi
Pages: 37-44
Published online: 02 Jul 2021
AbstractforEconomic evaluation of ivabradine in treatment of patients with heart failure: a systematic review | Full Text | References | PDF (542.6 KB) | EPUB
  • 197 Views
  • 2 CrossRef citations
  • 0Altmetric

Systematic Review

Pembrolizumab plus lenvatinib or axitinib compared to nivolumab plus ipilimumab or cabozantinib in advanced renal cell carcinoma: a number needed to treat analysis
Matteo Santoni, Alessandro Rizzo, Veronica Mollica, Matteo Rosellini, Andrea Marchetti, Benedetta Fragomeno, Nicola Battelli & Francesco Massari
Pages: 45-51
Published online: 15 Jun 2021
AbstractforPembrolizumab plus lenvatinib or axitinib compared to nivolumab plus ipilimumab or cabozantinib in advanced renal cell carcinoma: a number needed to treat analysis | Full Text | References | PDF (2.6 MB) | EPUB
  • 751 Views
  • 4 CrossRef citations
  • 0Altmetric

Original Research

Article
A systematic review and meta-regression of studies eliciting willingness-to-pay per quality-adjusted life year in the general population
Ziping Ye, Jia Ma, Fuyao Liu, Chen Wang, Ziyang Zhou & Lihua Sun
Pages: 53-61
Published online: 01 Feb 2021
AbstractforA systematic review and meta-regression of studies eliciting willingness-to-pay per quality-adjusted life year in the general population | Full Text | References | PDF (1.3 MB) | EPUB | Supplemental
  • 257 Views
  • 4 CrossRef citations
  • 0Altmetric
Article
Cost-effectiveness analysis of trastuzumab for early breast cancer in Brazil
Carlos Henrique Botelho, Maria Del Pilar Estevez-Diz & Alessandro Gonçalves Campolina
Pages: 63-72
Published online: 28 Jul 2021
AbstractforCost-effectiveness analysis of trastuzumab for early breast cancer in Brazil | Full Text | References | PDF (1.6 MB) | EPUB | Supplemental
  • 301 Views
  • 0 CrossRef citations
  • 0Altmetric

Original research

Article
Cost-effectiveness analysis of using innovative therapies for the management of moderate-to-severe ulcerative colitis in Spain
Carlos Taxonera, Fernando de Andrés-Nogales, Santiago García-López, Amelia Sánchez-Guerrero, Belén Menchén, Carmen Peral, Ana Cábez, Susana Gómez, Alejandra López-Ibáñez de Aldecoa, Miguel Ángel Casado & Luis Menchén
Pages: 73-83
Published online: 20 Feb 2021
AbstractforCost-effectiveness analysis of using innovative therapies for the management of moderate-to-severe ulcerative colitis in Spain | Full Text | References | PDF (2 MB) | EPUB
  • 3325 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access
Article
Cost-effectiveness of adding durvalumab to first-line chemotherapy for extensive-stage small-cell lung cancer in China
Guoqiang Liu & Shuo Kang
Pages: 85-91
Published online: 25 Feb 2021
AbstractforCost-effectiveness of adding durvalumab to first-line chemotherapy for extensive-stage small-cell lung cancer in China | Full Text | References | PDF (2 MB) | EPUB | Supplemental
  • 286 Views
  • 10 CrossRef citations
  • 0Altmetric
Article
The affordability of adding a direct-acting oral anticoagulant to the national list of essential medicine for patients with non-valvular atrial fibrillation in Thailand: a budget impact analysis
Piyameth Dilokthornsakul & Unchalee Permsuwan
Pages: 93-100
Published online: 10 Feb 2021
AbstractforThe affordability of adding a direct-acting oral anticoagulant to the national list of essential medicine for patients with non-valvular atrial fibrillation in Thailand: a budget impact analysis | Full Text | References | PDF (1.7 MB) | EPUB | Supplemental
  • 132 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
The impact of hypoglycemia on healthcare costs: a modeling study from Chile
Carlos Balmaceda, Manuel A. Espinoza, Baltica Cabieses & Nazareth Espinoza
Pages: 101-106
Published online: 31 Dec 2020
AbstractforThe impact of hypoglycemia on healthcare costs: a modeling study from Chile | Full Text | References | PDF (329 KB) | EPUB
  • 126 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
A comparison of six approaches for measuring utility values among patients with locally advanced cervical cancer
Kanyarat Katanyoo, Montarat Thavorncharoensap, Usa Chaikledkaew & Arthorn Riewpaiboon
Pages: 107-117
Published online: 06 Apr 2021
AbstractforA comparison of six approaches for measuring utility values among patients with locally advanced cervical cancer | Full Text | References | PDF (2.3 MB) | EPUB
  • 96 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Acceptability and willingness to pay for a hypothetical vaccine against SARS CoV-2 by the Brazilian consumer: a cross-sectional study and the implications
Isabella Piassi Dias-Godói, Túlio Tadeu Rocha Sarmento, Edna Afonso Reis, Ludmila Peres Gargano, Brian Godman, Francisco de Assis Acurcio, Juliana Alvares-Teodoro, Augusto Afonso Guerra Júnior & Cristina Mariano Ruas
Pages: 119-129
Published online: 14 Jun 2021
AbstractforAcceptability and willingness to pay for a hypothetical vaccine against SARS CoV-2 by the Brazilian consumer: a cross-sectional study and the implications | Full Text | References | PDF (639.8 KB) | EPUB
  • 202 Views
  • 8 CrossRef citations
  • 0Altmetric
Article
Accounting for inflation within NICE cost-effectiveness thresholds
Vincent Low & Richard Macaulay
Pages: 131-137
Published online: 18 Jun 2021
AbstractforAccounting for inflation within NICE cost-effectiveness thresholds | Full Text | References | PDF (2.5 MB) | EPUB
  • 196 Views
  • 1 CrossRef citations
  • 0Altmetric

Original Research

Article
An early cost analysis of magnetic bone growth stimulation in England
Joel Russell, Sheila Sprague, Sam Harper, Michelle Green & Mohit Bhandari
Pages: 139-145
Published online: 26 Apr 2021
AbstractforAn early cost analysis of magnetic bone growth stimulation in England | Full Text | References | PDF (661.3 KB) | EPUB | Supplemental
  • 4617 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Changes in treatment pattern and costs in advanced hepatocellular carcinoma (HCC)
Noemi Muszbek, Rachel Evans, Edit Remak, Victoria K Brennan, Fabien Colaone, Suki Shergill, Paul Ross & Damian Mullan
Pages: 147-154
Published online: 06 Sep 2021
AbstractforChanges in treatment pattern and costs in advanced hepatocellular carcinoma (HCC) | Full Text | References | PDF (814.5 KB) | EPUB | Supplemental
  • 2102 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Meta-analysis

Comparative efficacy and safety of rimegepant, ubrogepant, and lasmiditan for acute treatment of migraine: a network meta-analysis
Karissa Johnston, Evan Popoff, Alison Deighton, Parisa Dabirvaziri, Linda Harris, Alexandra Thiry, Robert Croop, Vladimir Coric, Gilbert L’Italien & James Moren
Pages: 155-166
Published online: 02 Jul 2021
AbstractforComparative efficacy and safety of rimegepant, ubrogepant, and lasmiditan for acute treatment of migraine: a network meta-analysis | Full Text | References | PDF (7.7 MB) | EPUB | Supplemental
  • 7532 Views
  • 5 CrossRef citations
  • 0Altmetric
Open Access

Explore articles